Phase II Study of Treatment for HPV16+ ASC-US, ASC-H and LSIL
Clinical trial NCT03911076 · TERMINATED
Trial details
- NCT number
- NCT03911076
- Sponsor
- PapiVax Biotech, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-22
- Primary completion
- 2022-06-08
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.